Advertisement

Index by author

November 01, 1999; Volume 291,Issue 2

  1. Emond, Patrick

    1. Pharmacological Characterization of (E)-N-(3-iodoprop-2-enyl)-2β-Carbomethoxy-3β-(4′-methylphenyl)nortropane as a Selective and Potent Inhibitor of the Neuronal Dopamine Transporter
      Sylvie Chalon, Lucette Garreau, Patrick Emond, Luc Zimmer, Marie-Paule Vilar, Jean-Claude Besnard and Denis Guilloteau
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 648-654;

  2. Englert, Heinrich C.

    1. ATP-Sensitive Potassium Channel Blocker HMR 1883 Reduces Mortality and Ischemia-Associated Electrocardiographic Changes in Pigs with Coronary Occlusion
      Klaus J. Wirth, Björn Rosenstein, Jörg Uhde, Heinrich C. Englert, Andreas E. Busch and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 474-481;

  3. Epstein, Paul N.

    1. A Transgenic Model of Acetaldehyde Overproduction Accelerates Alcohol Cardiomyopathy
      Qiangrong Liang, Edward C. Carlson, Anthony J. Borgerding and Paul N. Epstein
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 766-772;

  4. Erhard, Karl F.

    1. Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis
      Michael W. Lark, George B. Stroup, Shing Mei Hwang, Ian E. James, David J. Rieman, Fred H. Drake, Jeremy N. Bradbeer, Ashwini Mathur, Karl F. Erhard, Kenneth A. Newlander, Stephen T. Ross, Kevin L. Salyers, Brian R. Smith, William H. Miller, William F. Huffman and Maxine Gowen
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 612-617;
Back to top

In this issue

Advertisement